Find an expert

I am a senior researcher with cross-disciplinary expertise in health economics, pharmacy practice, and virtual health solutions. I am passionate about optimising healthcare outcomes by developing economically sustainable services that use technology and artificial intelligence to empower patients. My work explores the economic efficiency of implementing either virtual health or advanced-scope clinician initiatives within the Australian health system to improve patient care.

I am also a clinical pharmacist with more than a decade of experience in patient care and clinician training. I am a health economist at the UQ School of Pharmacy and Phamaceutical Sciences, and I lead the research work in the Pharmacy Department at the Princess Alexandra Hospital in Brisbane.

Christine graduated with a Bachelor of Pharmacy degree (honours class 1) from the University of Queensland in 1996.

She registered as a pharmacist in Australia in 1997 and in the United Kingdom in 2003 and has worked at the Redlands, Princess Alexandra and Wesley Hospitals in Brisbane and the Western Infirmary in Glasgow. In 2002 she was awarded a PhD from the University of Queensland, with a thesis focusing on improving usage of the immunosuppressant agent tacrolimus in solid organ transplant recipients.

In 2004 she was the recipient of a National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley fellowship. This award enabled her to training overseas in the field of Pharmacometrics within the Department of Medicine and Therapeutics at the University of Glasgow (Scotland) and the Department of Pharmaceutical Biosciences at Uppsala University (Sweden).

On her return to Brisbane, Christine was the recipient of a Lions Medical Research Fellowship and was the chief investigator on a three year NHMRC Project Grant. She has also been a team member on an Amgen-Transplant Society of Australia and New Zealand Research Grant and a Cellcept Australia Research Grant. Over her research career Christine has attracted grants and awards totaling more than 2 million AUD from various funding agencies.

Research Interests

Christine has a wide range of interests in the fields of Quality Use of Medicine and Pharmacometrics. Her work to date has primarily been directed towards optimising usage of immunosuppressant drugs in solid organ transplant recipients and antibiotics in patients with life-threatening infections.

Christine has published over 120 peer reviewed papers and 150 conference abstracts on these topics. Her publications have been cited on more than 8200 occasions.

Christine has successfully supervised to completion fourteen higher research degree students and enjoys helping students meet their career goals.

Christine’s current projects include:

• Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
• Comparing the efficacy and safety of continuous versus intermittent administration of beta-lactams in critically ill patients
• Examining the relationship between immunosuppression and non-melanoma skin cancer in renal transplant recipients
• Improving individualisation of immunosuppressant therapy in adult kidney transplant recipients
• Improving gentamycin dosing in paediatric oncology patients
• Examining tobramycin monitoring in cystic fibrosis patients in Australia and the United Kingdom
• Investigating the relationship between prednisolone exposure and drug-related toxicity in paediatric and adult kidney transplant recipients
• Comparing different therapeutic drug monitoring methods for dosage adjustment of once daily intravenous tobramycin treatment in children with cystic fibrosis

Projects currently available for interested research higher degree students include:

• Dose optimisation of busulfan in paediatric bone marrow transplant recipients
• Investigating the relationship between immunosupressant exposure and drug-related toxicity in transplant recipients
• Examining Bayesian forecasting methods to predict immunosuppressant exposure
• Examining the international use of immunosuppressant and anti-rheumatic drugs
• Examining the influence of plasma exchange on immunosuppressant drug exposure

Christine invites potential honours and post-graduate students to contact her via email to discuss research opportunities.

Teaching interests

Co-ordinates:

• PHRM3052- Biological Fate of Drugs

• PHRM2500- Pharmacokinetics and Medicines Management

• PHRM7001- Quality Use of Medicines, Drug Pharmacokinetics and Drug Pharmacodynamics

Teaches in:

• PHRM3052- Biological Fate of Drugs
• PHRM3011- Quality Use of Medicines

I completed my Bachelor of Pharmacy at Kings College London, followed by pre-registration and subsequent employment as a pharmacist with Boots the Chemists in Central London. With a PhD in plant biochemistry with Royal Holloway College, University of London, and the Royal Botanic Gardens, Kew, I moved first to Cornell University, USA and then The University of Western Australia for postdoctoral research. I moved to the School of Pharmacy at The University of Queensland in 2007.

Following a number of years in plant research, my current research interests generally link back to plants in some way. Many of my projects develop in response to requests for help from healthcare professionals, and so I have a strong focus on answering clinical questions using pharmaceutical science methods. See my research interests for more information. I am not currently accepting new PhD students as primary supervisor, but am open to contributing as an associate advisor.

I currently teach into the Bachelor of Pharmacy (Honours) in the areas of pharmaceutics, compounding and complementary medicines, and previously have contributed to education in areas of pharmacy practice, clinical trial management, and pharmaceutical chemistry. I have supervised over 30 PhD students to completion, and over 60 undergraduate and masters independent research project students.

I am a medicinal and organic chemist

Studied organic chemistry at the University of Sydney, moved to UQ in 1993, then worked for Bayer in Germany, before moving back to Australia in 1996. Worked in Melbourne at the Victorian College of Pharmacy (now MIPS). I then returned to UQ in 2000 to the Fairlie lab where we design and synthesise new chemical entities to tackle human disease. Since 2012 I have been on extended medical leave and am currently an Adjunct Research Fellow, researching proteins from flaviviruses such as Dengue, West Nile, and Zika viruses, and the coronaviruses SARS, MERS, and SARS-CoV-2.

Critical Care Medicine focuses on supporting patients, often with one or multiple organ failures. Based at the largest Australian cardiac hospital, our research investigates better ways to support patients with heart and/or lung failure. We explore technological, pharmacological and engineering advances that could help our patients to live longer and better. Our group is world-renowned for clinically relevant large animal models, including heart failure, respiratory failure (ARDS), heart transplantation, sepsis, cardiogenic shock, and more. All our studies use hospital-grade equipment and follow the same clinical guideline to maximise translation. We actively take on honours, MPhil and PhD students from multi-disciplinary backgrounds (science, engineering, medicine, allied health), with a successful track record in supporting our students to secure their own grants and funding. Students are expected to contribute to other studies of the group. For more information about the group, please visit ccrg.org.au, and email if you are interested to join us.

Tim is a clinical academic pharmacist and lecturer working at the School of Pharmacy and the Princess Alexandra Hospital. He graduated with a Bachelor of Pharmacy at the University of Queensland in 2014. After working as a mental health pharmacist at the Princess Alexandra Hospital, he became interested in schizophrenia and psychopharmacology. He completed his PhD with the School of Medicine in 2026 and his research interests include clozapine, treatment-resistant schizophrenia, and the safe use of antipsychotic medicines. He is the team leader of mental health pharmacy at the Princess Alexandra Hospital. Tim teaches into the Bachelor of Pharmacy and the Masters of Clinical Pharmacy programmes at the University of Queensland, and supervises research project placements.

Dr Yonas Tefera is a Research Fellow in psychiatric epidemiology at the Queensland Centre for Mental Health Research (QCMHR), University of Queensland. He specialises in leveraging epidemiological methods and conducting advanced analyses of large-scale population-level administrative datasets related to hospital admissions and primary care. As an epidemiologist, his expertise spans pharmacoepidemiology and health services research. In his current work, he leads linked data analysis of health service data, including hospital, emergency department, community mental health services, and public dental care for people living with mental illness. In addition to health service use, his linked data alnalyses include outcomes for individuals engaged with mental health tribunals and placed on treatment orders. Dr Tefera's interests encompass psychiatric epidemiology, psychopharmacology, pharmacoepidemiology, and the use of advanced statistical and machine learning approaches to understand and enhance care for individuals living with mental illness or substance use problems.

He completed his PhD at Monash University in late 2025, focusing on opioid and psychotropic medicine use among injured Australian workers with back and neck musculoskeletal disorders. His work examined high-risk medicine use patterns, such as initiation, persistence, and co-prescribing of opioids and psychotropics, as well as their impacts on work-related outcomes in this population. His research has improved the understanding of value-based healthcare in Australian workers' compensation schemes. Dr Tefera possesses substantial expertise in diverse clinical research methodologies, robust evidence synthesis, and quantitative data analysis, including causal inference techniques. His experience includes survey-based studies, analysis of multinational surveys, international aggregate datasets, and linked administrative and claims data, as well as injury compensation datasets.

Before undertaking his PhD, Dr Tefera trained as a clinical pharmacist and worked as a lecturer, clinical preceptor, and mentor at the University of Gondar in Ethiopia, teaching courses such as pharmacotherapy, drug informatics, evidence-based medicine, and pharmacoepidemiology. He earned a Master of Public Health with distinction from the University of Manchester and a Master of Science in Clinical Pharmacy from the University of Gondar. His academic excellence has been recognised with several honours, including the Outstanding Student Cup Award from the Ethiopian Pharmaceutical Association and the first-place award for achieving the highest score in his graduating class at the University of Gondar. Additionally, he has received multiple travel grants to present his research at national and international conferences, such as the International Pharmaceutical Federation's World Pharmaceutical Congress and the International Society for Pharmacoepidemiology's Asian Conference on Pharmacoepidemiology.

Professor Susan Tett is a registered pharmacist with research interests in Quality Use of Medicines (improving how medicines are used) and clinical pharmacokinetics (optimising medicine doses)

Sue completed her PhD in 1988. Since this time she has been in research positions and in academia at Sydney University, St Vincent’s Hospital, Sydney and at the University of Queensland. She has over 150 peer reviewed research publications and over 200 conference presentations and is on Editorial Board of Clinical Pharmacokinetics. Sue was Head of the School of Pharmacy, University of Queensland 1996-2004 and Deputy Executive Dean & Associate Dean Research for the Faculty of Health Sciences 2006-2010, including periods as Acting Executive Dean.

Susan Tett has been a member of many Australian national and State advisory committees, including Pharmaceutical Health and Rational use of Medicines Committee 1996-2004, Pharmaceutical Sub-Committee of the Australian Drug Evaluation Committee 1995-2004, Pharmaceutical Industry Working Group 2003-10 , Pharmaceutical Partnerships Program Committee of the Industry Research & Development Board 2003-09, and has participated in NHMRC Project Grant Review Panels and Fellowships Panels. She was also Councillor for the Pharmaceutical Society of Australia (Queensland Branch) and was the Australian Pharmacist of the Year in 1999, for her contributions to pharmacy education and research.

Sue’s research interests are directed towards optimising the clinical use of medications. General areas of research include quality use of medicines, clinical pharmacokinetics and pharmacodynamics. Sue supervises a number of postgraduate students and is actively involved in innovation in the pharmacy profession, pushing the professional boundaries. She is committed to enhancing the role of the health care team in optimising consumer health outcomes.

I am an NHMRC Leadership Fellow with joint apointments at the Institute for Molecular Bioscience (IMB) and School of Pharmacy, UQ. My research interests lie in the fields of peripheral pain mechanisms, target identification and analgesic drug discovery. I investigate the contribution of ion channels to sensory neuronal physiology using highly subtype-selective toxins isolated from venomous animals with the aim to develop novel analgesics with improved efficacy and tolerability.

Dr Haolu Wang currently is a Medical Registrar and Basic Physician Trainee with the Royal Australasian College of Physicians - The Prince Charles Hospital and Redcliffe Hospital (Northside) Rotation. He is also an Honorary Research Fellow in the joint liver cancer research program of Frazer Institute, The University of Queensland and Gallipoli Medical Research Foundation. Dr Wang received his Bachelor of Medicine and Master of Surgery qualifications from Shanghai Jiao Tong University School of Medicine. He was awarded his PhD in Clinical Medicine from The University of Queensland. Dr Wang has worked as a Medical Officer at Renji Hospital, Shanghai Jiao Tong University School of Medicine and as a Researcher Officer at Frazer Institute, The University of Queensland.

Dr Wang has authored over 30 publications of clinical and translational research in liver diseases, including Hepatology, Theranostics, Int J Cancer, J Exp Clin Cancer Res and Pharmacol Ther. His standing in this field is reflected by awards from Australian National Health and Medical Research Council, United European Gastroenterology, European Microscopy Congress, The University of Queensland, Frazer Family Foundation and Shanghai Jiao Tong University.

Dr Yanan Wang is a Postdoc at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland. She obtained her PhD degree from Ocean University of China and joined AIBN in early 2026.

Dr Wang’s research focuses on the development of stimulus-responsive and targeted drug delivery systems for the treatment of acute organ injuries and inflammatory diseases. In addition, her current work also aims to develop engineering multifunctional nanomedicine for cancer immunotherapy, with particular interests in innate immune modulation, dendritic cell-mediated antitumour immunity, and the tumour immunosuppressive microenvironment reprogramming for enhancing cancer treatment.

Dr Wang has published 23 papers in international top refereed journals such as ACS Nano, Advanced science, Biomaterials, Chemical Engineering Journal, and so on.

Associate Professor

Pharmacy Australia Centre of Excellence Email: karen.whitfield@uq.edu.au

Dr Karen Whitfield is an Associate Professor within the School of Pharmacy and is the Program Lead for the Master of Clinical Pharmacy.https://future-students.uq.edu.au/study/programs/master-clinical-pharmacy-5718

Karen was awarded the Research Excellence Award for Research Support - Metro North Health Service in 2020 and the Australian Clinical Pharmacist awarded by the Society of Hospital Pharmacists of Australia in 2017

Karen has worked at a number of different hospital including Royal Brisbane and Women's Hospital, Leicester Royal Infirmary, Leicester General Infirmary, North Staffordshire Hospital Trust (Surgical and Paediatric Directorate Pharmacist), The Townsville Hospital. Most recently she has worked at the Royal Brisbane and Women’s Hospital (from 2015-2021) holding several positions including, Team Leader Women's and Newborns and Assistant Director Cancer Care Services. She has also held a number of teaching positions including, Sr Lecturer James Cooke University, Teacher Practitioner with Medicines Services Queensland and lecturer with the University of Queensland.

Her specialist interests include Women's Health and Neonatology

She completed a Diploma in Hospital Pharmacy (1991), Masters in Clinical Pharmacy (1996) and completed her PhD at Aston University in 2002 under the supervision of Dr John Marriott and Dr Keith Wilson at the Birmingham Children’s Hospital UK, investigating sedatives in the Paediatric Intensive Care Unit.

Karen has presented work Nationally and Internationally at several Seminars and Conferences including, Life Long Learning for Pharmacists Conference (Dublin 2020, Croatia 2016), FIP webinar series ‘Hearing from our Hero’s’ (2020), Monash Pharmacy Education Symposium (2019), MM2018 SHPA Conference Brisbane (2018), Neonatal and Paediatric Pharmacists Conference UK (2015), Society of Obstetric Medicine Australia and New Zealand (Melbourne 2015).

Dr Woodruff is a Professor of Pharmacology who leads a research team aiming to find new therapeutic treatments for neurodegenerative disorders. Current therapies for these diseases are vastly inadequate, and so new research is needed to identify novel targets to slow or halt their progression. Prof Woodruff’s specific research revolves around the innate immune system in the brain, and the role of neuroinflammation in propagating disease. A key focus of his current work is testing new drugs developed at the University of Queensland in models of motor neuron disease (amyotrophic lateral sclerosis), Huntington’s disease, and Parkinson's disease, as well as maintaining an active interest in acute inflammatory disorders including sepsis and ischemia-reperfusion injuries. Using a series of potent and orally active complement C5a and NLRP3 inflammasome inhibitors developed at UQ, Prof Woodruff's team has demonstrated the therapeutic potential of targeting innate immune-mediated neuroinflammation to reduce neuronal cell death in animal models of these neurodegenerative diseases. His team has recently shown that in addition to their roles in neurodegeneration, innate immune factors also play essential roles in stem and neuronal cell development during embryogenesis, revealing the widespread physiological and pathological roles of this evolutionarily ancient immune system.

Dr Jun Yan is a molecular biologist, currently working in the field of neurological diseases. Dr Yan's research interest is cell signal transduction pathways invoved in mechanisms of the disease development.

Dr Jun Yan completed her postgraduate study at The University of Queensland, after which she undertook a postdoctoral position in Experimental Oncology laboratory in Department of Patholody, UQ and worked on Ras / Raf signalling pathway. In 2001 she joined the Neuroimmunology Research group in Department of Medicine, UQ, and works on neurological diseases, including autoimmune disease multiple sclerosis (MS), ischaemic stroke and amyotrophic lateral sclerosis (ALS) . She has been investigating NF-kB signal transduction pathway in MS and ALS, and cell immune responese to ischaemic stroke.